Helius Medical Technologies, Inc. announced the expansion of the registrational program with the addition of Brooks Rehabilitation Hospital. The program, structured on the basis of encouraging results from an early trial as well as real-world evidence from Canada, where PoNS is already authorized for treatment of stroke, focuses on establishing the effects of cranial-nerve non-invasive neuromodulation ("CN-NINM"), delivered using PoNS Therapy??, on gait and dynamic balance in chronic stroke survivors. Brooks Rehabilitation will participate as an adjunct site, under the direction of Dr. Mark Bowden, PT, PhD, Vice President of Clinical Integration and Research, to the ongoing investigator-initiated, placebo-controlled study in stroke, led by Dr. Steven Kautz at the Medical University of South Carolina ("MUSC").

Dr. Bowden will also take part in additional clinical activities that, when combined with the randomized controlled study, aim to bring the total number of subjects enrolled in the clinical program to approximately 100. Starting in January 2024, Dr. Bowden anticipates enrolling approximately 40 participants to the development program at Brooks Rehabilitation and expects full enrollment by the end of the year.